In the past years, different research projects have been conducted in an effort to find a more efficient and accurate way of carrying out the clinical pathway for prostate cancer (PCa) diagnosis.
Our current development work focuses on building an exhaustive medical image analysis software suite for prostate and neurodegenerative diseases. This includes a range of relevant biomarkers for neurovascular and neuro-oncological conditions. Additionally, we are working on multiple products in the realm of oncology.
B-Q MINDED is a collaboration of strong industry partners and hospitals, which aims to develop faster Quantitative Magnetic Resonance Imaging (Q-MRI) technology and accelerating it for use in routine clinical practice.
The ID-PROSTATE Project focuses on the further improvement and acceleration of Quantib's AI-enhanced integrated diagnostic solution for the detection of potential tumors and workflow optimization involving urologists, radiologists and pathologists.
The feature portfolio of Quantib® ND has recently been extended with white matter hyperintensity detection, reference centile curves for brain volumes and follow-up functionalities.
To further improve the performance of our medical image analysis software we are actively gathering and processing customer feedback. Do you want to learn more about the current functionalities?
We are committed to developing an AI software solution to support radiologist when reading Prostate MRIs in order to improve the clinical pathway of prostate cancer (PCa).
We actively gather and implement customer feedback in order to further improve the performance of our medical image analysis software.
Do you want to know which specific functionalities does Quantib® Prostate have?